(E)-[(2,6-Dichlorophenyl)methoxy]({[6-(phenylsulfanyl)imidazo[2,1-b][1,3]thiazol-5-yl]methylidene})amine

Catalog No. :
ACQJHC139
CAS No. :
339022-80-9
Molecular Formula :
C19H13Cl2N3OS2
Molecular Weight :
434.37

IUPAC Name:(E)-6-(phenylthio)imidazo[2,1-b]thiazole-5-carbaldehyde O-(2,6-dichlorobenzyl) oxime

(E)-[(2,6-Dichlorophenyl)methoxy]({[6-(phenylsulfanyl)imidazo[2,1-b][1,3]thiazol-5-yl]methylidene})amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-[(2,6-Dichlorophenyl)methoxy]({[6-(phenylsulfanyl)imidazo[2,1-b][1,3]thiazol-5-yl]methylidene})amine
IUPAC Name(E)-6-(phenylthio)imidazo[2,1-b]thiazole-5-carbaldehyde O-(2,6-dichlorobenzyl) oxime
Molecular FormulaC19H13Cl2N3OS2
Molecular Weight434.37
SMILESClC1=C(CO/N=C/C2=C(SC3=CC=CC=C3)N=C4SC=CN42)C(Cl)=CC=C1
InChI KeySRRQSANQMMQIGM-SSDVNMTOSA-N
Synonym6-(PHENYLSULFANYL)IMIDAZO[2,1-B][1,3]THIAZOLE-5-CARBALDEHYDE O-(2,6-DICHLOROBENZYL)OXIME;(E)-[(2,6-dichlorophenyl)methoxy]({[6-(phenylsulfanyl)imidazo[2,1-b][1,3]thiazol-5-yl]methylidene})amine;Imidazo[2,1-b]thiazole-5-carboxaldehyde, 6-(phenylthio)-, O-[(2,6-dichlorophenyl)methyl]oxime
CAS No.339022-80-9

Synthetic Route by SureRoute

1. ACQJHC139 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBDXE076 route compound structure diagram
    ACBDXE0763111-52-2
  4. Then
  5. ACQJHC139 route product structure diagram
    ACQJHC139339022-80-9
Inquiry

2. ACQJHC139 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQJHC139 route product structure diagram
    ACQJHC139339022-80-9
Inquiry

Comments (0)